Kennedy Capital Management LLC Takes $5.42 Million Position in Rapport Therapeutics, Inc. $RAPP
MarketBeat
Kennedy Capital Management LLC bought a new stake in Rapport Therapeutics, Inc. (NASDAQ:RAPP - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 178,737 shares of the company's stock, valued at approximatel
NASDAQ:RAPP